Open AccessPre-Exposure Prophylaxis (PrEP) in the Prevention of HIV: Strategies, Target Populations and Upcoming Treatments
Author(s) -
Ayşe Elif Özdener-Poyraz,
Malgorzata Slugocki,
Julie Kalabalik-Hoganson,
Jayoung Han
Publication year - 2020
Publication title -
hiv/aids
Language(s) - English
Resource type - Journals
ISSN - 1179-1373
DOI - 10.2147/hiv.s216024
Subject(s) - emtricitabine , pre exposure prophylaxis , tenofovir , misinformation , medicine , human immunodeficiency virus (hiv) , intensive care medicine , antiretroviral therapy , immunology , viral load , men who have sex with men , computer science , computer security , syphilis
Pre-exposure prophylaxis (PrEP) against HIV infection with tenofovir/emtricitabine is proven to be effective yet uptake of this preventive measure has been difficult due to several barriers such as cost, access, and misinformation. Certain subpopulations are disproportionately affected by this problem. Several methods have been developed to close the gap in care. New antiretroviral treatment strategies are being investigated for safety and efficacy in preventing HIV infection.